Another study, conducted by Lui et al., indicates an increased risk of ALL relapse in patients with a mutation in the phosphoribosyl pyrophosphate synthetase 1 gene (PRPS). The gene discussed is PRPS1; the disease is acute lymphoblastic leukemia.